Evidence map›Paper›PMID 28405006›Full record

ArticleScientific reports2017

The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment - from preclinical perspectives.

Lin Li, Grace Gar-Lee Yue, Julia Kin-Ming Lee, Eric Chun-Wai Wong, Kwok-Pui Fung, Jun Yu, Clara Bik-San Lau, Philip Wai-Yan Chiu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. International journal of molecular sciences · 2026
    Article
  3. Biomedical reports · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Mechanisms of Natural Extracts ofInternational journal of molecular sciences · 2022
    Review
  9. Anti-cancer activity of heteroaromatic acetals of andrographolide and its isomers.New journal of chemistry = Nouveau journal de chimie · 2022
    Article
  10. Review
  11. A comparative assessment ofRSC advances · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Oncology letters · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lin LiDepartment of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Grace Gar-Lee YueInstitute of Chinese Medicine and State Key Laboratory of Phytochemistry and Plant Resources in West China (CUHK), The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Julia Kin-Ming LeeInstitute of Chinese Medicine and State Key Laboratory of Phytochemistry and Plant Resources in West China (CUHK), The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Eric Chun-Wai WongInstitute of Chinese Medicine and State Key Laboratory of Phytochemistry and Plant Resources in West China (CUHK), The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Kwok-Pui FungInstitute of Chinese Medicine and State Key Laboratory of Phytochemistry and Plant Resources in West China (CUHK), The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Jun YuDepartment of Medicine and Therapeutics and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Clara Bik-San LauInstitute of Chinese Medicine and State Key Laboratory of Phytochemistry and Plant Resources in West China (CUHK), The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. claralau@cuhk.edu.hk.ORCID http://orcid.org/0000-0002-7409-1270
Philip Wai-Yan ChiuDepartment of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. philipchiu@surgery.cuhk.edu.hk.
Chinese University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal cancer (EC) is the fourth and sixth leading cause of cancer-related deaths in China and United States, respectively. The dismal prognosis of EC is mainly attributed to distant metastases, which may not be overcome by chemotherapy alone. Hence, the use of alternative adjuvant treatments, such as herbal medicines, for metastatic EC remains a great desire of patients. Our previous study demonstrated the in vivo anti-tumor and in vitro anti-invasion activities of Andrographis paniculata (AP) in esophageal cancer. In the present study, the chemical constituents of absorbed AP components through human intestinal Caco-2 cell monolayer were verified for the first time. The anti-migratory activities and suppressive effects on metastasis-related factors such as HER2, MMP2, MMP9, TM4SF3, CXCR4 of the absorbed AP components were revealed in esophageal cancer cells EC-109. The anti-tumor and anti-metastatic effects of AP water extract (1600 mg/kg) were further confirmed in metastatic esophageal xenograft-bearing mice. Besides, AP water extract acted synergistically with cisplatin plus 5-fluorouracil on inhibiting tumor nodule growth (with combination index <0.7). Meanwhile, chemotherapeutics-induced side-effects could also be reduced by AP water extract. The present findings provide evidence on safety and advantages of the combined use of AP with chemotherapeutics in pre-clinical setting.

Indexed as

Adjuvants, PharmaceuticAndrographisAnimalsAntineoplastic AgentsCaco-2 CellsCell Line, TumorCell MovementCisplatinErb-b2 Receptor Tyrosine KinasesEsophageal NeoplasmsFluorouracilHumansMaleMatrix MetalloproteinasesMiceMice, Inbred BALB CAdjuvants, PharmaceuticAntineoplastic AgentsCisplatinErb-b2 Receptor Tyrosine KinasesFluorouracilMatrix MetalloproteinasesPlant ExtractsReceptors, CXCR4Tetraspanins

Identifiers

PMID28405006
PMCPMC5429803
OpenAlexW2605142832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.